Resonance-Based Chinese Five-Element Music Intervention(RFEMI) plus pharmacotherapy groupResonance-Based Chinese Five-Element Music Intervention(RFEMI) plus pharmacotherapy group
Resonance-Based Chinese Five-Element Music Intervention(RFEMI) plus pharmacotherapy group: received standard pharmacotherapy plus RFEMI. RFEMI was based on TCM Five-Element theory, zang-fu emotion correspondence, and resonance-informed acoustic delivery.
Resonance-Based Chinese Five-Element Music Intervention(RFEMI) plus pharmacotherapy group: received standard pharmacotherapy plus RFEMI. RFEMI was based on TCM Five-Element theory, zang-fu emotion correspondence, and resonance-informed acoustic delivery.
Study summary
This randomized controlled trial will evaluate the effectiveness of Resonance-Based Chinese Five-Element Music Intervention (RFEMI) as an adjunct to pharmacotherapy in male inpatients with depressive disorders. Based on Traditional Chinese Medicine Five-Element tone theory and resonance-informed acoustic delivery, RFEMI will be compared with conventional music intervention plus pharmacotherapy and pharmacotherapy alone over a four-week intervention period. The study will assess changes in depressive and anxiety symptoms, TCM syndrome characteristics, neuroendocrine biomarkers, cerebral oxygenation, and autonomic nervous system regulation.
Eligibility
Sex
MALE
Min age
18 Years
Max age
44 Years
Healthy volunteers
No
Inclusion Criteria:
* meeting both the ICD-11 diagnostic criteria for depressive episode or recurrent depressive disorder and the TCM diagnostic criteria for Yu disease
* diagnosis confirmed by two senior clinical physicians
* planned inpatient stay longer than six weeks
* no antidepressant medication in the previous six months and no music therapy in the previous year
* male sex, age 18-44 years, junior secondary education or above, clear consciousness, and ability to communicate effectively
* no other major physical disease or mental disorder
* voluntary written informed consent and complete clinical records.
Exclusion Criteria:
* depression due to organic mental disorder, psychoactive substance use, or non-addictive substance use
* serious organic disease or unstable vital signs
* suicidal or violent tendency, or refusal to cooperate with treatment
* hearing impairment
* inability to follow the intervention protocol
* incomplete scale data or clinical records.
Primary outcome measure(s)
Hamilton Depression Rating Scale (HAM-D) — 3 months A widely used clinician-administered questionnaire used to assess the severity of depressive symptoms and monitor changes in patients diagnosed with depression. The lowest possible score is 0 (indicating the absence of depressive symptoms), and the highest score on the most commonly used 17-item scale is 52.
Trial sites (1)
Facility
City
Region
Status
Datong Maternal and Child Health Hospital (formerly Datong First People's Hospital), Shanxi, China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.